Amarin Corp Plc (AMRN)

[jessellivermore]

metsfan...

Excellent post...I am not a lawyer and don't think like a lawyer..

Quote from metsfan's post) "5) **My assumption** Amarin is in the process of ramping up R&D of icosapent ethyl by investigating other uses (pointing out the BRAVE study for Alzheimer's Disease, any COVID-19 studies, and other potential indications such as DES). This decision will cause Amarin to drastically cut R&D in the US, with a potential "significant negative impact on public welfare" by affecting these other patient groups."

Could this issue be considered a secondary consideration. Ie. unexpected consequences .The generics are not designed to do continuing research on possible new breakthrough indications for Vascepa...And with the loss of USA revenues (due not only to the loss of the high trig indication but the loss of the R-I indication by off labeling). Will put Amarin in a position where it will lack the resources and the motivation to continue to developing new and very important life saving indications such as Alzheimer's...And the court would be doing a terrible thing to the people of the world in preventing this research to continue. Particularly considering judge Du's verdict is rife with factual errors.

I would compare a vote at the appellate court to sustain Judge Du's verdict as no different than Cyril's decision to burn the great Library at Alexandria...

":>) JL